Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Mersana Therapeutics Inc
About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is a cytotoxic ADC platform that is designed to generate site-specific, homogeneous ADCs. Immunosynthen is its proprietary stimulator of interferon genes (STING)-agonist platform that is designed to generate systemically administered ADCs that locally activate STING signaling in both antigen-expressing tumor cells and in tumor-resident immune cells. The Company's pipeline includes Emi-Le (emiltatug ledadotin; XMT-1660), a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).
Find out what a historical investment in Mersana Therapeutics Inc would be worth today using our MRSN stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy MRSN shares in Australia?
Buying MRSN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Mersana Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MRSN
What is the ticker symbol of Mersana Therapeutics Inc?
The ticker symbol for Mersana Therapeutics Inc is MRSN.
How much is one share of MRSN?
One share of MRSN is valued at $29.08 as of 22 May 2026.
What is the market capitalisation of Mersana Therapeutics Inc MRSN?
As of 22 May 2026 Mersana Therapeutics Inc has a market cap of -.
What is the 52-week high for Mersana Therapeutics Inc stock?
The Mersana Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Mersana Therapeutics Inc stock?
The Mersana Therapeutics Inc 52-week low stock price is $NaN.
Can I buy MRSN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MRSN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MRSN on Stake
- Buy MRSN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MRSN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MRSN related stocks